Ownership Summary
Quarter ending 30 Jun, 2026
Tempest Therapeutics, Inc. (NASDAQ:TPST) has 1 institutional investors with active 13F positions as of June 2026.
- They owned 6.5% of outstanding stock in June 2026, down from 6.5% the prior quarter.
- They maintained total shares held in TPST by 0.0% quarter over quarter, and investors in Tempest Therapeutics stayed flat from a year ago.
- Among the 1 funds, 0 bought more Tempest Therapeutics shares, 0 sold down, and 1 held their ground.
- In total, institutional investors held 269.77K shares in Tempest Therapeutics as of June 2026, with no net change quarter on quarter, and with no net change year over year.
- Versant Venture Management, LLC is the top holder of Tempest Therapeutics as of June 30, 2026, with 269.77K shares representing 6.5% of outstanding stock.
- Tempest Therapeutics's 1 largest shareholders as of June 2026 include Versant Venture Management, LLC (269.77K) per Business Quant data.